Silvestre OM, Bacal F, de Souza RD, Andrade JL, Furtado M, Pugliese V, Belleti E, Andraus W, Carrilho FJ, Carneiro DLA, Queiroz FA

Idioma: Ingles.
Referencias bibliográficas: 36
Paginas: 85-91
Archivo PDF: 114.31 Kb.

RESUMEN

Sin resumen.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Zardi EM, Abbate A, Zardi DM, Dobrina A, Margiotta D, Van Tassel BW, Afeltra A, et al. Cirrhotic Cardiomyopathy. J Am Coll Cardiol 2010; 56: 539-49.

2. Møller S, Hobolth L, Winkler C, Bendtsen F, Christensen E. Determinants of the hyperdynamic circulation and central hypovolaemia in cirrhosis. Gut 2011; 60: 1254-59.

3. Rodríguez-Roisin R, Krowka MJ, Hervé P, Fallon MB. Pulmonary- hepatic vascular disorders: a task force report. Eur Respir J 2004; 24: 861-80.

4. Ma Z, Lee SS. Cirrhotic cardiomyopathy: getting to the heart of the matter. Hepatology 1996; 24: 451-9.

5. Møller S, Henriksen JH. Cardiovascular complications of cirrhosis. Gut 2008; 57: 268-78.

6. Valeriano V, Funaro S, Lionetti R, Riggio O, Pulcinelli G, Fiore P, Masini A, et al. Modification of cardiac function in cirrhotic patients with and without ascites. Am J Gastroenterol 2000; 95: 3200-5.

7. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-71.

8. Huo TI, Lee SD, Lin HC. Selection an optimal prognostic system for liver cirrhosis: the model for end-stage liver diseases and beyond. Liver Int 2008; 28: 606-13.

9. Freeman RB Jr, Wiesner RH, Harper A, McDiarmid SV, Lake J, Edwards E, Merion R, Wolfe R, et al. The new liver allocation system: moving toward evidence-based transplantation policy. Liver Transpl 2002; 8: 851-8.

10. Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club. Hepatology 1996; 23: 164-76.

11. Douglas PS, DeCara JM, Devereux RB, Duckworth S, Gardin JM, Jaber WA, Morehead AJ, et al. Echocardiographic imaging in clinical trials: American Society of Echocardiography Standards for Echocardiography core laboratories. J Am Soc Echocardiogr 2009; 22: 755-65.

12. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63.

13. Nagueh SF, Appleton CP, Gillebert TC, Marino, Oh JK, Smiseth AO, Waggoner AD, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-33.

14. Rabie RN, Cazzaniga M, Salerno F, Wong F. The use of E/A ratio as a predictor of outcome in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt. Am J Gastroenterol 2009; 104: 2458-66.

15. Merion RM. When is a patient too well and when is a patient too sick for a liver transplant? Liver Transpl 2004; 10: S69-S73.

16. Møller S, Henriksen JH. Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease. Heart 2002; 87: 9-15.

17. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling. J Am Coll Cardiol 2000; 35: 569-82.

18. Schrier RW, Arroyo V, Bernard N, Epstein M, Henriksen JH, Rodes J. Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology 1988; 8: 1151-7.

19. Lewis FW, Adair O, Rector WG Jr. Arterial vasodilation is not the cause of increased cardiac output in cirrhosis. Gastroenterology 1992; 102: 1024-9.

20. Pozzi M, Carugo S, Boari G, Pecci V, de Ceglia S, Maggiolini S, Bolla GB, et al. Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites. Hepatology 1997; 26: 1131-7.

21. Wong F, Liu P, Lilly L, Bomzon A, Blendis L. Role of cardiac structural and functional abnormalities in the pathogenesis of hyperdynamic circulation and renal sodium retention in cirrhosis. Clinical Science 1999; 97: 259-67.

22. Ripoll C, Catalina MV, Yotti R, Olmedilla L, Perez-Pena J, Lo Iacono O, Rincón D, et al. Cardiac dysfunction during liver transplantation: incidence and preoperative predictors. Transplantation 2008; 85: 1766-72.

23. De BK, Majumdar D, Das D, Biswas PK, Mandal SK, Ray S, Bandopadhyay K, et al. Cardiac dysfunction in portal hypertension among patients with cirrhosis and non-cirrhotic portal fibrosis. J Hepatol 2003; 39: 315-9.

24. Gottdiener JS, Kitzman DW, Aurigemma GP, Arnold AM, Manolio TA. Left atrial volume, geometry and function in systolic and diastolic heart failure of persons=65 years of age (the cardiovascular health study). Am J Cardiol 2006; 97: 83-9.

25. Benjamin EJ, D’Agostino RB, Belanger AJ, Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995; 92: 835-41.

26. Zamirian M, Aslani A, Shahrzad S. Left atrial volume: a novel predictor of hepatopulmonary syndrome. Am J Gastroenterol 2007; 102: 1392-6.

27. Krowka MJ, Mandell MS, Ramsay MAE, Kawut SM, Fallon MB, Manzarbeitia C, Pardo M Jr, et al. Hepatopulmonary syndrome and portopulmonary hypertension: A report of the multicenter liver transplant database. Liver Transpl 2004; 10: 174-82.

28. Braverman AC, Steiner MA, Picus D, White H. High-output congestive heart failure following transjugular intrahepatic portal-systemic shunting. Chest 1995; 107: 1467-9.

29. Ginès P, Uriz J, Beymer C, Calahorra, Garcia-Tsao G, Kamath PS, Del Arbol LR, et al. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis. Gastroenterology 2002; 123: 1839-47.

30. Snowden CP, Hughes T, Rose J, Roberts JRD. Pulmonary edema in patients after liver transplantation. Liver Transpl 2000; 6: 466-70.

31. Safadi A, Homsi M, Maskoun W, Lane KA, Singh I, Sawada SG, Mahenthiran J. Perioperative Risk Predictors of Cardiac Outcomes in Patients Undergoing Liver. Circulation 2009; 120: 1189-94.

32. Fouad TR, Abdel-Razek WM, Burak KW, Bain VG, Lee S. Prediction of cardiac complications after liver transplantation. Transplantation 2009; 87: 763-70.

33. Hammermeister KE, DeRouen TA, Dodge HT. Variables predictive of survival in patients with coronary disease. Selection by univariate and multivariate analyses from the clinical, electrocardiographic, exercise, arteriographic and quantitative angiographic values. Circulation 1979; 59: 421-30.

34. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 1990; 81: 1161-72.

35. Ruiz-del-Arbol L, Monescillo A, Arocena C, Valer P, Ginès P, Moreira V, Milicua JM, et al. Circulatory function and hepatorenal syndrome in cirrhosis. Hepatology 2005; 42: 439-47.

36. Lapa M, Dias B, Jardim C, Fernandes CJ, Dourado PM, Figueiredo M, Farias A, et al. Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 2009; 119: 1518-23.